Drug patents …
… from Kazakhstan to Kalamazoo
Find generic entry opportunities
Anticipate generic drug launch
Proactively manage your pharmacy inventory
Manage your formulary budget
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Methods for inhibition of membrane fusion-associated events, including influenza virus|
|Abstract:||The present invention relates to peptides which exhibit potent anti-retroviral activity. The peptides of the invention comprise DP178 (SEQ ID:1) peptide corresponding to amino acids 638 to 673 of the HIV-1.sub.LAI gp41 protein, and fragments, analogs and homologs of DP178. The invention further relates to the uses of such peptides as inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells.|
|Inventor(s):||Barney; Shawn O'Lin (Cary, NC), Lambert; Dennis Michael (Cary, NC), Petteway; Stephen Robert (Cary, NC)|
|Assignee:||Trimeris, Inc. (Durham, NC)|
|Filing Date:||Jun 07, 1995|
|Claims:||1. A method for the inhibition of transmission of an influenza A virus to a cell, comprising contacting the cell with an effective concentration of an influenza virus peptide, said peptide identified through the use of a computer algorithm which utilizes an ALLMOTI5, 107x178x4 or a PLZIP sequence search motif, for an effective period of time so that no infection of the cell by the virus occurs. |
2. A method for the inhibition of transmission of an influenza A virus to a cell, comprising contacting the cell with an effective concentration of a peptide having the formula:
X-QAAIDQINGKLNRVIEKTNEKFHQIEKEFS EVEGRIQDLEKYVEDTKIDLWSYNAELLVALENQHTI-Z (SEQ ID NO. 210); or
X-AADLKSTQAAIDQINGKLNRVIEKTNEKFHQIEKEFS EVEGRIQDLEKYVEDTKIDLWSYNAELLVALENQHTIDLT-Z (SEQ ID NO. 211),
X comprises an amino group, an acetyl group, a 9-fluorenylmethoxy-carbonyl group, a hydrophobic group, or a macromolecule carrier group; and
Z comprises a carboxyl group, an amido group, a hydrophobic group, or a macromolecular carrier group.
3. The method of claim 2 wherein the peptide has the formula:
X-QAAIDQINGKLNRVIEKTNEKFHQIEKEFS EVEGRIQDLEKYVEDTKIDLWSYNAELLVALENQHTI-Z (SEQ ID NO. 210).
4. The method of claim 2 wherein the peptide has the formula:
X-AADLKSTQAAIDQINGKLNRVIEKTNEKFHQIEKEFS EVEGRIQDLEKYVEDTKIDLWSYNAELLVALENQHTIDLT-Z (SEQ ID NO. 211).
5. The method of claim 2, 3, or 4 wherein X is an acetyl group, and Z is an amido group.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.